Literature DB >> 8203468

Mechanisms of transthyretin amyloidogenesis. Antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations.

A Gustavsson1, U Engström, P Westermark.   

Abstract

Transthyretin (TTR) is the major amyloid fibril protein in senile systemic amyloidosis and in several forms of familial amyloidoses. However, the internal organization of the fibrils is virtually unknown. It is not known whether the structure of the TTR molecules is substantially altered within the fibrils. In this study we used various antigenic mapping procedures to determine whether major antigenic sites differ between normal TTR, ATTR (TTR from amyloid fibrils), and in situ amyloid fibrils. Antigenic mapping was achieved using standard immunological procedures (ie, ELISA, Western blot, and immunohistochemistry), synthetic peptides of the TTR molecule, antisera against these synthetic peptides and against normal TTR, ATTR, and alkali-degraded amyloid fibrils. Our results show that the antigenic sites on normal plasma TTR include the AB loop and the CD loop. The amino acid sequences associated with these loops are present on the outside of the TTR molecule. Antiserum against beta-strand H reacted only with TTR in amyloid fibrils and ATTR but not with normal plasma TTR or TTR in the islets of Langerhans. Our results suggest that there is an altered configuration of TTR within amyloid fibrils when compared with plasma TTR.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8203468      PMCID: PMC1887460     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  X-ray diffraction studies on amyloid filaments.

Authors:  E D Eanes; G G Glenner
Journal:  J Histochem Cytochem       Date:  1968-11       Impact factor: 2.479

2.  Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin.

Authors:  G G Cornwell; K Sletten; B Johansson; P Westermark
Journal:  Biochem Biophys Res Commun       Date:  1988-07-29       Impact factor: 3.575

3.  Localization of human prealbumin in choroid plexus epithelium.

Authors:  S L Aleshire; C A Bradley; L D Richardson; F F Parl
Journal:  J Histochem Cytochem       Date:  1983-05       Impact factor: 2.479

4.  Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A.

Authors:  C C Blake; M J Geisow; S J Oatley; B Rérat; C Rérat
Journal:  J Mol Biol       Date:  1978-05-25       Impact factor: 5.469

5.  Senile cardiac amyloid: evidence that fibrils contain a protein immunologically related to prealbumin.

Authors:  G G Cornwell; P Westermark; J B Natvig; W Murdoch
Journal:  Immunology       Date:  1981-11       Impact factor: 7.397

6.  Thyroxine-binding prealbumin. Conformation in aqueous solutions.

Authors:  D P Hanlon; L De Vore; M C Kincaid; A Jones; L Lane
Journal:  J Biol Chem       Date:  1971-10-10       Impact factor: 5.157

7.  Primary structure of an amyloid prealbumin and its plasma precursor in a heredofamilial polyneuropathy of Swedish origin.

Authors:  F E Dwulet; M D Benson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

8.  An inherited non-amyloidogenic transthyretin variant, [Ser6]-TTR, with increased thyroxine-binding affinity, characterized by DNA sequencing.

Authors:  N J Fitch; M T Akbari; D B Ramsden
Journal:  J Endocrinol       Date:  1991-05       Impact factor: 4.286

9.  Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type).

Authors:  S Tawara; M Nakazato; K Kangawa; H Matsuo; S Araki
Journal:  Biochem Biophys Res Commun       Date:  1983-11-15       Impact factor: 3.575

10.  Transthyretin immunoreactivity in human and porcine liver, choroid plexus, and pancreatic islets.

Authors:  B Jacobsson; V P Collins; L Grimelius; T Pettersson; B Sandstedt; A Carlström
Journal:  J Histochem Cytochem       Date:  1989-01       Impact factor: 2.479

View more
  10 in total

1.  Immunohistochemical examination of Aκ amyloidosis with antibody against adjacent portion of the carboxy terminus of immunoglobulin kappa light chain.

Authors:  Yoshinobu Hoshii; Hidemi Nanbara; Dan Cui; Mutsuo Takahashi; Eiji Ikeda
Journal:  Med Mol Morphol       Date:  2012-09-22       Impact factor: 2.309

2.  Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils.

Authors:  K Johan; G Westermark; U Engström; A Gustavsson; P Hultman; P Westermark
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

3.  Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid.

Authors:  B Häggqvist; J Näslund; K Sletten; G T Westermark; G Mucchiano; L O Tjernberg; C Nordstedt; U Engström; P Westermark
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

4.  Experimentally derived structural constraints for amyloid fibrils of wild-type transthyretin.

Authors:  David A Bateman; Robert Tycko; Reed B Wickner
Journal:  Biophys J       Date:  2011-11-15       Impact factor: 4.033

5.  Transthyretin Amyloid Cardiomyopathy: Impact of Transthyretin Amyloid Deposition in Myocardium on Cardiac Morphology and Function.

Authors:  Tomoya Nakano; Kenji Onoue; Chiyoko Terada; Satoshi Terasaki; Satomi Ishihara; Yukihiro Hashimoto; Yasuki Nakada; Hitoshi Nakagawa; Tomoya Ueda; Ayako Seno; Taku Nishida; Makoto Watanabe; Yoshinobu Hoshii; Kinta Hatakeyama; Yasuhiro Sakaguchi; Chiho Ohbayashi; Yoshihiko Saito
Journal:  J Pers Med       Date:  2022-05-13

6.  Novel Antibody for the Treatment of Transthyretin Amyloidosis.

Authors:  Akihiko Hosoi; Yu Su; Masaharu Torikai; Hirofumi Jono; Daisuke Ishikawa; Kenji Soejima; Hirofumi Higuchi; Jianying Guo; Mitsuharu Ueda; Genki Suenaga; Hiroaki Motokawa; Tokunori Ikeda; Satoru Senju; Toshihiro Nakashima; Yukio Ando
Journal:  J Biol Chem       Date:  2016-10-07       Impact factor: 5.157

7.  Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis.

Authors:  Elisabet Ihse; Ole B Suhr; Ulf Hellman; Per Westermark
Journal:  J Mol Med (Berl)       Date:  2010-11-25       Impact factor: 4.599

8.  Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin.

Authors:  Jeffrey N Higaki; Avi Chakrabartty; Natalie J Galant; Kevin C Hadley; Bradley Hammerson; Tarlochan Nijjar; Ronald Torres; Jose R Tapia; Joshua Salmans; Robin Barbour; Stephen J Tam; Ken Flanagan; Wagner Zago; Gene G Kinney
Journal:  Amyloid       Date:  2016-03-16       Impact factor: 7.141

Review 9.  Recent advances in transthyretin amyloidosis therapy.

Authors:  Mitsuharu Ueda; Yukio Ando
Journal:  Transl Neurodegener       Date:  2014-09-13       Impact factor: 8.014

10.  The pathological and biochemical identification of possible seed-lesions of transmitted transthyretin amyloidosis after domino liver transplantation.

Authors:  Tsuneaki Yoshinaga; Masahide Yazaki; Yoshiki Sekijima; Fuyuki Kametani; Kana Miyashita; Naomi Hachiya; Tomohiro Tanaka; Norihiro Kokudo; Keiichi Higuchi; Shu-Ichi Ikeda
Journal:  J Pathol Clin Res       Date:  2016-01-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.